(Q38479070)

English

Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection (English)

1 reference

Europe PubMed Central

3 September 2017

Pseudomonas aeruginosa

0 references

cystic fibrosis

0 references

Helle Krogh Johansen

1

object named as

Helle Krogh Johansen

0 references

Peter C. Gøtzsche

3

object named as

Peter C Gøtzsche

0 references

6

object named as

Niels Høiby

0 references

author name string

Lena Nørregaard

2

1 reference

Europe PubMed Central

3 September 2017

Tacjana Pressler

4

1 reference

Europe PubMed Central

3 September 2017

Christian Koch

5

1 reference

Europe PubMed Central

3 September 2017

Niels Høiby

6

1 reference

Europe PubMed Central

3 September 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

3 September 2017

Pediatric Pulmonology

1 reference

Europe PubMed Central

3 September 2017

37

1 reference

Europe PubMed Central

3 September 2017

5

1 reference

Europe PubMed Central

3 September 2017

427-432

1 reference

Europe PubMed Central

3 September 2017

Maintenance treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10457

21 January 2018

Identifiers

10.1002/PPUL.10457

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38479070&oldid=1761732466"